Quantum computing is accelerating, making post-quantum readiness increasingly urgent. The opportunity lies in the trusted hardware, identity systems, and network infrastructure needed to replace vulnerable encryption without disrupting critical services.
Article

Post-Quantum Security: The Hidden Upgrade

Google’s 2026 report on full quantum computing’s research showed that progress is accelerating and organizations should target post-quantum (PQ) readiness by 2029. Most companies, governments, and

29
23
44
2,051
AI’s soaring power demand is reviving nuclear energy, but advanced reactors face a critical bottleneck: HALEU fuel. With the West lacking commercial-scale supply, the asymmetric opportunity may lie in the few companies able to enrich uranium for it.
Article

HALEU: The Nuclear Bottleneck Nobody Owns

AI power demand is so high, it’s driving renewed interest in a high-potential but tainted sector: nuclear energy. While sentiment is warming up to nuclear once again, its main constraint has evolved

28
24
28
1,780
Brain-computer interfaces are improving recovery from strokes, spinal cord injuries, brain injuries, and neurological disease by translating brain signals into stimulation or robotic movement. The investment opportunity lies in the components behind them.
Article

The Neurorehabilitation Thesis: Next-Gen Therapy for Every Human

Technology is offering patients of strokes, spinal-cord injuries, brain injuries, and neurological diseases better treatment from a new frontier: the brain. For decades, the best treatment these

30
27
39
1,686
Personalized medicine is moving from standardized treatments to patient-specific therapies. As cancer vaccines gain clinical proof, the biggest opportunity may lie in the sequencing, AI, manufacturing, and delivery infrastructure that makes them scalable.
Article

The Personalized Medicine Thesis

Medicine is transforming from standardized remedies to personalized treatments. Biopharma spent decades optimizing the production of millions of identical doses. Individualized oncology asks the

36
30
42
1,716
Cheap drones have made scale the new defense imperative: millions of attritable aircraft and counter-drone systems. The investment opportunity lies in the shared bill of materials every drone and counter-drone maker must buy.
Article

The Drone Arms Race

Cheap drones have flipped the economics of war. A $500 first-person view (FPV) drone can destroy a vehicle worth orders of magnitude more, and no military can answer that with just a handful of

29
27
39
2,097
AI power demand is outrunning grids, and solar plus storage is the only solution fast and cheap enough to close the gap. China dominates the supply chain at unmatched scale and margins, yet its global leaders remain priced for a domestic price war.
Article

China’s Energy Dominance

AI power demand is outrunning grids, turbines, and transmission, and solar-plus-storage is the only thing deployable fast and cheap enough to close the gap. That hardware (cells, modules, inverters,

33
32
36
2,319
Humanoid brands are headed for a war of attrition, but the suppliers underneath them get paid for every robot built, no matter who wins. Joints, actuators, and sensors are the trade. Exotic.
Article

The Humanoid Supply Chain: Own the Body, Not the Brand

The humanoid robotics sector doesn't need a single winning brand to create an investable opportunity. Every machine still needs the same joints, actuators, and sensors, sourced from a small group of

36
33
49
2,927
Staffing shortages, not scientific breakthroughs, will define healthcare's next cycle. The winning tools are the ones that help current staff see more patients without adding headcount. Exotic.
Article

The Nurse Is Not Coming: Healthcare Tech as a Labor Shortage Trade

Healthcare's next technology boom will be driven by a basic constraint: there aren't enough people to care for an aging population. Hospitals can't solve that shortage through hiring alone, so they'll

50
32
48
2,231